4//SEC Filing
KEMPHARM, INC 4
Accession 0001209191-16-098955
$ZVRACIK 0001434647operating
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:33 PM ET
Size
5.8 KB
Accession
0001209191-16-098955
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Guenther Sven
Exec VP R&D
Transactions
- Award
Stock Option (right to buy)
2016-02-11+50,000→ 50,000 totalExercise: $12.62Exp: 2026-02-10→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on February 11, 2017 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer. The option expires ten years after the date of grant.
Documents
Issuer
KEMPHARM, INC
CIK 0001434647
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001434647
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 6:33 PM ET
- Size
- 5.8 KB